5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
about
Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophyEnergy disruptors: rising stars in anticancer therapy?AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase.Electroacupuncture inhibits weight gain in diet-induced obese rats by activating hypothalamic LKB1-AMPK signaling.Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling.Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitisUtilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesisAntidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-A(y) Diabetic Mice.Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells.Skeletal muscle insulin resistance: roles of fatty acid metabolism and exerciseRelative Contribution of Intramyocellular Lipid to Whole-Body Fat Oxidation Is Reduced With Age but Subsarcolemmal Lipid Accumulation and Insulin Resistance Are Only Associated With Overweight Individuals.A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.Targeting the AMPK pathway for the treatment of Type 2 diabetes.Beyond AICA riboside: in search of new specific AMP-activated protein kinase activators.Can patients with type 2 diabetes be treated with 5'-AMP-activated protein kinase activators?AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.Perivascular fat, AMP-activated protein kinase and vascular diseases.Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes.Advances in the development of AMPK-activating compounds.AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease.5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects.Activation of AMPK and its Impact on Exercise Capacity.Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation.Role of AMP-Activated Protein Kinase for Regulating Post-exercise Insulin Sensitivity.A novel role for AMP-kinase in the regulation of the Na+/I--symporter and iodide uptake in the rat thyroid gland.Sustained AMPK activation improves muscle function in a mitochondrial myopathy mouse model by promoting muscle fiber regeneration.5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis.Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status.Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle.An acute bout of endurance exercise but not sprint interval exercise enhances insulin sensitivity.AMPK in skeletal muscle function and metabolism.Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators.Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep.
P2860
Q24634396-8C04C25B-0869-429E-A81A-978F0DC1580FQ26771300-AB4B1D78-E9A5-46BE-B201-45064EAEFCFCQ33655490-815471DF-53B5-46E8-B646-E36E89119B39Q33822976-0EEA1C1B-EC96-4110-8AB3-06DEB79EDA74Q34412650-2D253D73-D401-4FCD-A8F0-6A182E76BADFQ34611635-4863628E-9BAF-494F-84A0-CABD65F5CB7FQ35627476-BB52F166-8820-4C76-B95F-FD72AF62A698Q35884554-57204F5C-6DF6-45EB-B664-6E0D6C03BA36Q36082770-D47B69CF-1F95-4D67-B759-145AA1C9823EQ36209248-03F7CCD0-606E-467F-A44E-BE4707CB5AB9Q36210664-9EA94417-28E3-449D-977B-FAA947BD2424Q36585576-81B8BD92-5AF2-4F45-A377-3F3A2ADA1548Q36780632-C7E75705-916D-4030-B7E8-2B7F2171C515Q36965630-575AFBEC-C6CD-4B03-86B0-3E5DE4D50225Q36972682-F2DB7880-005F-4D5C-B5E3-6385D72F20A5Q37170305-B5019044-0673-4C71-9159-03E547397A48Q37180980-0948E996-8B26-45BC-B615-B6804B0B5CCDQ37271886-F95CE7ED-D5D0-4ECE-AF6C-E1F0C81FD4BAQ37313758-65944114-1465-4746-9F70-448345B1549FQ37401935-E95F461C-B56C-4BF3-AB95-A9A20BBBF1F5Q37411713-81DDF967-3D12-4AEC-BBC1-A3C6AE1A611FQ37671282-17E24627-A151-40AE-AE2F-C742FE7BEA11Q38082465-2E615777-74F9-4995-8529-8EE27DDA8EA8Q38089174-993DFA8A-769F-4C98-8711-EB6C50C2A728Q38211516-A5B7EC36-B932-430B-B1A4-6ACE19A3E29AQ38222605-E09C8F0C-DE9A-412B-A3DA-DC94F8FA16CBQ38549546-5C671512-D0E5-4A6E-A639-6A341E455B2CQ38945736-CCF6F4AA-C832-4D7C-9FDA-95D8A3DC3A60Q38998401-DE1916A9-FD75-4F51-978B-14AE9F7E5E31Q39578634-D696BD0C-4F15-410A-B9D9-2669351EEBB8Q39732168-DA583207-8703-4E4A-BEC1-B428C3716B80Q40644641-D95BEA3A-BFCC-420F-BB37-B0D55417DD55Q42077416-45210DDC-F8E1-484C-A1F7-86F8F6BC9FA5Q45929265-2013595B-7426-4E59-AEDE-CB6953343F27Q46113676-12F8FA8D-8852-45CB-AB9D-C15A0B135947Q47781006-2F1AC0EE-73DA-43D3-837C-DA8A0B9FBC77Q54351819-80C6B793-BD01-40EA-98CE-33011CF5FE6EQ54365047-01848218-646B-4F87-A753-9F5DE74DB541Q54462222-60F79BDA-48EC-47B2-93C0-A060BEF4D113
P2860
5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@ast
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@en
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@nl
type
label
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@ast
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@en
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@nl
prefLabel
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@ast
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@en
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@nl
P2093
P356
P1433
P1476
5-aminoimidazole-4-carboxamide ...... glucose uptake in healthy men.
@en
P2093
D Grahame Hardie
Graeme P Leese
Henning Wackerhage
John A Babraj
Keith Baar
Kevin A Green
Kirsteen J W Mustard
Mhairi C Towler
Michael J Rennie
Michaela Thomason-Hughes
P304
P356
10.2337/DB06-1716
P407
P577
2007-05-18T00:00:00Z